Voltage gated sodium channels (VGSCs) were first identified in terms of their role in the upstroke of the action potential. The underlying proteins were later identified as saxitoxin and scorpion toxin receptors consisting of a and b subunits. We now know that VGSCs are heterotrimeric complexes consisting of a single pore forming a subunit joined by two b subunits; a noncovalently linked b1 or b3 and a covalently linked b2 or b4 subunit. VGSC a subunits contain all the machinery necessary for channel cell surface expression, ion conduction, voltage sensing, gating, and inactivation, in one central, polytopic, transmembrane protein. VGSC b subunits are more than simple accessories to a subunits. In the more than two decades since the original cloning of b1, our knowledge of their roles in physiology and pathophysiology has expanded immensely. VGSC b subunits are multifunctional. They confer unique gating mechanisms, regulate cellular excitability, affect brain development, confer distinct channel pharmacology, and have functions that are independent of the a subunits. The vast array of functions of these proteins stems from their special station in the channelome: being the only known constituents that are cell adhesion and intra/extracellular signaling molecules in addition to being part of channel complexes. This functional trifecta and how it goes awry demonstrates the power outside the pore in ion channel signaling complexes, broadening the term channelopathy beyond defects in ion conduction.
Introduction
Voltage gated sodium channels (VGSCs) were first identified functionally in terms of their role in the upstroke of the action potential (AP) (Hille, 2001) . The underlying proteins were later identified as saxitoxin and scorpion toxin receptors consisting of a and b subunits (Hartshorne et al., 1982; Messner and Catterall, 1985) . We now know that VGSCs are heterotrimeric complexes consisting of a single pore forming a subunit joined by two b subunits; a noncovalently linked b1 or b3 and a covalently linked b2 or b4 subunit (Isom and De Jongh, 1992; Isom et al., 1995; Morgan et al., 2000; Yu et al., 2003) . Mammalian genomes contain 9 VGSC a subunits, encoded by the SCN(1e10)A genes, and 5 b subunits, encoded by the SCN(1e4)B genes (Catterall et al., 2005) . VGSC a subunits contain all the machinery necessary for channel cell surface expression, ion conduction, voltage sensing, gating, and inactivation, in one central, polytopic, transmembrane protein (Auld et al., 1988) . Early electrophysiological results led to the misconception that b subunits are simple accessories to a subunits (Goldin et al., 1986) . However, in the 25 years since the original cloning of the first b subunit, their role has expanded immensely (Isom and De Jongh, 1992) . VGSC b subunits confer unique gating mechanisms, regulate cellular excitability, affect brain development, confer distinct channel pharmacology, and have functions that are independent of the a subunits. The vast array of functions of these proteins stems from their special station in the channelome: being the only known constituents that are cell adhesion and intra/ extracellular signaling molecules in addition to being part of channel complexes (Isom et al., 1994; Brackenbury and Isom, 2011) . This functional trifecta and how it goes awry demonstrates the power outside the pore in ion channel signaling complexes, broadening the term channelopathy beyond defects in ion conduction. This review will focus on VGSC b subunits in the nervous system. To read about b subunit function in heart, cancer, and beyond see: Bao and Isom, 2014; Martin et al., 2015; Namadurai et al., 2015; O'Malley and Isom, 2015) .
Section 1: structure and expression of b subunits
Excluding b1b, the VGSC b subunits have type 1 membrane protein topology consisting of an extracellular N-terminal domain, a single transmembrane segment, and a C-terminal tail ( Fig. 1 ) (Isom and De Jongh, 1992; Isom et al., 1995; Kazen-Gillespie et al., 2000; Morgan et al., 2000; Yu et al., 2003) . The array of functions and interactions imparted by each of these domains make b subunits immensely powerful for such small proteins. b subunit functionality in brain is expanded even further if one takes into account their expression profiles in terms of developmental time course, cell type specificity, and subcellular localization. This section will examine the structure and expression of b subunits in the nervous system.
Section 1 part 1: the b subunit immunoglobulin domain
Each VGSC b subunit features an extracellular N-terminal domain that contains homology to V-type immunoglobulin (Ig) loops common to the Ig superfamily of cell adhesion molecules (CAMs) (Isom and De Jongh, 1992; Isom et al., 1995; Kazen-Gillespie et al., 2000; Morgan et al., 2000; Yu et al., 2003) . In the b subunits, these domains are capable of both interaction with VGSC a subunits and cell adhesion . Each Ig domain consists of antiparallel b sheets stabilized by an intrasubunit disulfide bond (McCormick et al., 1998; Gilchrist et al., 2013; Namadurai et al., 2014; Das et al., 2016; Shimizu et al., 2016) .
Early on, b subunit structure was modeled based on the crystal structure of the extracellular domain of myelin P0, a protein containing a single V type Ig loop and single transmembrane domain with modest homology to b1 and b3 (Isom et al., 1995; McCormick et al., 1998; Morgan et al., 2000) . Crystal structures of b2, b3, and b4
were recently solved in isolation or in complexes with each other. (Gilchrist et al., 2013; Namadurai et al., 2014; Das et al., 2016) .
Subsequently the crystal structure of b1 in complex with Na v 1.4 from electric eel was solved (Yan et al., 2017) . These structures inform and confirm many insights into b subunit Ig domains garnered from previous biochemical work and show that each subunit contains unique structural features. Approximately onethird of the molecular mass of each b subunit is due to N-linked glycosylation moieties in the extracellular domain (Isom and De Jongh, 1992; Isom et al., 1995; McCormick et al., 1998; Morgan et al., 2000; Yu et al., 2003; Johnson et al., 2004) . Sialic acid terminated glycosylation is necessary for modulation of a subunit gating by b1, suggesting that electrostatic interactions with voltage sensing domains may occur through modification of these residues (Johnson et al., 2004) . VGSC b1 and b3 subunits share the highest percentage of sequence identity to each other, while b2 and b4 share a higher percentage of sequence identity to each other than to either b1 or b3 (Isom and De Jongh, 1992; Isom et al., 1995; Morgan et al., 2000; Yu et al., 2003) . Studies using chimeric subunits revealed that b1 modulates the gating of Na v 1.2 via association with the extracellular domain IV S5-S6 region of that a subunit Qu et al., 1999) . This may extend to b3, given its high sequence similarity to b1, although see (Namadurai et al., 2014) . The site of association between b1 and Nav1.4 was localized to the S5-S6 segments, at the interface of domains I and IV, implicating channel specific regions of interaction (Makita et al., 1996) . This was recently confirmed with the crystal structure of b1 in complex with Na v 1.4 with additional interaction sites in the transmembrane and intracellular segments of b1 (Yan et al., 2017) . b2 and b4 bind to VGSC a subunits differently than b1 and b3. A key difference between the Ig loops of the b subunits is the presence of an exposed free cysteine residue in b2 and b4 that forms a disulfide bond with a subunits (Isom et al., 1995; Yu et al., 2003) . Mutation of this residue in b2 or b4 abolishes a subunit interactions (Chen et al., 2012; Gilchrist et al., 2013) . The cysteine residues in b2 (Cys-26) or b4 (Cys-58) responsible for covalent association with a were determined to bind to a corresponding cysteine residue in Na v 1.2 located in the domain II S5-S6 loop (Das et al., 2016) . This residue is absent from the tetrodotoxin-resistant (TTX-R) a subunits Nav1.5, Nav1.8 and Nav1.9, although Nav1.5 and b2 have been shown to associate through disulfide bonds in cardiac tissue and b2 modifies Nav1.5 currents in heterologous systems and in vivo Johnson and Bennett, 2006; Bao et al., 2016) . b2 and b4 differentially affect channel modulation of a subunits by extracellular m-, mO-and mOx-conotoxins relative to b1 and b3 (Wilson et al., 2011; Zhang et al., 2013; Gajewiak et al., 2014; Wilson et al., 2015) . In the case of mOx-conotoxins, association with a subunits occurs through the same cysteine through which these subunits covalently bind to VGSC a subunits. b1 and b3 have no influence on mOxconotoxin effects (Gajewiak et al., 2014) . Thus, as expected from early data showing that VGSCs in brain are heterotrimers, these results suggest that the binding sites for b1 and b3 vs b2 and b4 on a subunits are mutually exclusive.
In addition to channel modulation, b subunits, in particular b1, participate in homophilic and heterophilic cell adhesion through their extracellular Ig domains. This property allows b subunits to interact with a wide variety of proteins in both cis and trans configurations, including with identical b subunits in the same membrane or on adjacent cells .
Importantly, b subunit-mediated cell adhesive interactions can occur both in the presence and absence of VGSC a subunits (Malhotra et al., 2000) . b subunit-mediated cell adhesion is most well characterized for b1, which associates homophilically in vitro in trans, and heterophilically with the Ig CAMs VGSC b2, contactin-1, Nf-186, and NrCam, with the adhesion molecule N-cadherin, and with the extracellular matrix molecule tenascin-R (Isom and Catterall, 1996; Malhotra et al., 2000; Kazarinova-Noyes et al., 2001; Ratcliffe et al., 2001; . b2 associates homophilically as well as heterophilically with b1 and tenascin-C, but not with contactin (Srinivasan et al., 1998; Xiao et al., 1999; . b4 engages in homophilic cell-cell adhesion but its ability to function as a heterophilic CAM has not been tested (Shimizu et al., 2016) . Crystal structure guided photocrosslinking experiments with b1 and b4 revealed the specific residues responsible for homophilic cell adhesion, further elucidating the structure of VGSC complexes (Shimizu et al., 2016) .
Interestingly, b3 is predicted to form trimeric complexes that would obscure the analogous residues necessary for trans homophilic adhesion (Namadurai et al., 2014) . These results are consistent with earlier data showing that, while b1 or b2 subunit expression in Drosphila S2 cells resulted in the formation of high affinity aggregates, b3 expression did not (McEwen et al., 2009 ). Overall, however, data on the cell adhesive properties of b3 are conflicting, possibly as an effect of differential trimerization based on expression system (Yereddi et al., 2013) .
2.2. Section 1 part 2: the transmembrane and C-terminal domains of b subunits b subunits contain a single, a helical transmembrane domain that can confer unique functional properties. For example, the structure of the b3 transmembrane domain is proposed to mediate cis homophilic interactions allowing for trimerization (Namadurai et al., 2014) . Trimeric b3 complexes are capable of forming oligomers with Nav1.5, a departure from the canonical heterotrimeric VGSC structure (Namadurai et al., 2014) . Interaction with the third voltage sensing domain of Na v 1.4 occurs through the transmembrane domain of b1, providing an additional potential means for modification of voltage sensing (Yan et al., 2017) . For Scn1b, retention of intron 3 through alternative splicing results in the polypeptide b1b, a secreted, soluble CAM. In place of a transmembrane domain, b1b contains an alternate C-terminus with an amino acid sequence that is species specific . b1b acts as an extracellular CAM ligand. It is also capable of modulation of Na v 1.5 but not Na v 1.1 or Na v 1.3 in heterologous systems (Watanabe et al., 2008; Patino et al., 2011) . b subunits can also shed their Ig domain following sequential cleavage by b-Site APP-cleaving enzyme 1 (BACE1) and g-secretase (Wong et al., 2005 ; VGSCs contain a pore-forming a subunit consisting of four homologous domains of six transmembrane segments (Catterall, 2012) . Segment 4 contains the voltage sensor. VGSCs also contain one or more b subunits. b1, b2, b3, and b4 contain an extracellular immunoglobulin (Ig) loop, transmembrane domain, and an intracellular C-terminal domain (O'Malley and Isom, 2015) . b1B also contains an Ig loop, but has a different C-terminus lacking a transmembrane domain, and is thus a soluble, secreted protein (Patino et al., 2011) . b1 contains a tyrosine phosphorylation site in its C-terminus (Malhotra et al., 2004) j, glycosylation sites. b1 and b3 are non-covalently linked to a, whereas b2 and b4 are covalently linked through disulfide bonds (O'Malley and Isom, 2015) . Figure was modified from . Gersbacher et al., 2010) . The resulting soluble extracellular fragment is likely to behave similarly to b1b.
b subunit intracellular C-terminal domains are short sequences predicted to have disordered structure Lewis and Raman, 2011; Namadurai et al., 2014) . Along with the transmembrane segment, the intracellular tails confer additional interactions with VGSC a subunits. Co-expression of b1 or b3 with Nav1.3 in heterologous cells attenuates lidocaine binding to the channel, suggesting that the b subunit C-terminal domains may occlude the a subunit local anesthetic binding site, located on the S6 helix of domain IV, and accessible only from the intracellular side (Lenkowski et al., 2003; Catterall, 2012) . Mutations in Scn1a
identified an additional a-b1 subunit interaction site in the b1 Cterminal tail (Spampanato et al., 2004) . The crystal structure of the Na v 1.4-b1 complex suggests the C-terminal tail may modify inactivation through an allosteric blocking mechanism (Yan et al., 2017) .
The intracellular domain of b2 modulates Nav1.5 gating and the Cterminal tail of b4 contains residues capable of intracellular blockade of a subunits to generate resurgent sodium current (I Na ) (described in section 2) (Grieco et al., 2005; Zimmer and Benndorf, 2007) . b subunit intracellular domains may also impart intracellular regulatory control of a and b subunit activity. For example, phosphorylation of b3 residue S161 is necessary for modulation of Nav1.2 I Na (Merrick et al., 2010) . The b1 intracellular tyrosine residue Y181 is required for b1 association with the scaffolding proteins ankyrin-B and ankyrin-G at points of cell-cell contact following trans homophilic cell adhesion (Malhotra et al., 2000; Merrick et al., 2010) . Phosphorylation of this residue prevents ankryin binding . and Isom, 2015) . In whole brain, b1b and b3 mRNA and protein expression are high during the prenatal and early postnatal period in mammals Shah et al., 2001; Patino et al., 2011) . These subunits then give way to increased expression of b1, b2, and b4 mRNA protein in the first postnatal week and this expression persists through adulthood (Sutkowski and Catterall, 1990; Isom and De Jongh, 1992; Isom et al., 1995; Sashihara et al., 1996; Lein et al., 2007) . Different cell types in the brain express different b subunits at various levels. In situ hybridization and immunohistochemistry show that Scn1b and b1 expression, respectively, are ubiquitous throughout the brain but with modest heterogeneity (Sashihara et al., 1996; BlackburnMunro and Fleetwood-Walker, 1999, Lein et al., 2007; Brackenbury and Isom, 2011; Wimmer et al., 2015) . b1 immunohistochemical studies show subcellular localization in similar patterns to that found for a subunits, with high density at axon initial segments (AISs) and nodes of Ranvier in myelinated axons Wimmer et al., 2010; Kruger, O'Malley et al., 2016) . This subcellular localization pattern allows for specialized functions. Exemplary of the importance of subcellular localization is the action of b1 at nodes of Ranvier. b1 is highly enriched in the nodal gap where it is presumed to modulate VGSC a subunit cell surface expression and gating. However, in the paranodal region b1 is engaged in a trimeric axonal-glial cell adhesion complex consisting of axonal b1, contactin, and Caspr binding in trans to glial neurfascin-155 in the absence of VGSC a subunits (Kazarinova-Noyes et al., 2001; . b1 expression at the growth cones of developing neurons mediates several important functions where it is proposed to act both as a CAM and as a modulator of I Na (Brackenbury et al., 2010) . Scn1b is also the mostly highly expressed b subunit gene in the peripheral nervous system (PNS), where it is particularly enriched in medium and large diameter A fibers with lower expression in C fibers (Blackburn-Munro and FleetwoodWalker, 1999, Lopez-Santiago et al., 2006; Zhao, O'Leary et al., 2011) . Scn2b expression is similarly ubiquitous in adult brain as assessed through in situ hybridization (Blackburn-Munro and Fleetwood-Walker, 1999; Lein et al., 2007) . Similar to b1, b2 protein is highly expressed at the AIS and nodes of Ranvier. Scn2b is also expressed in the PNS, where its deletion results in loss of responsiveness to inflammatory and neuropathic pain but not mechanosensation, again suggesting cell type specific functions (Lopez-Santiago et al., 2006; Zhao, O'Leary et al., 2011) .
While Scn3b mRNA and protein are expressed ubiquitously throughout the developing CNS, in adult mice expression is greatly attenuated except in specific structures, most highly in hippocampus and others (Morgan et al., 2000; Lein et al., 2007) . This differs in human brain, where SCN3B expression remains highly expressed through adulthood similarly to SCN3A (Chen et al., 2000; Lein et al., 2007) . PNS expression of Scn3b is especially high in unmyelinated C fibers and is low in the other fiber types (LopezSantiago et al., 2006; Zhao, O'Leary et al., 2011) .
Scn4b is the most restricted of the b subunits in its expression profile. Scn4b mRNA and protein are highly expressed in several neuronal populations, many of which are known for spontaneous or burst firing APs (Lein et al., 2007; Lewis and Raman, 2014) . The highest expression of b4 protein and Scn4b mRNA are found in the striatum and cerebellar purkinje neurons but are also highly expressed in other restricted brain regions (Lein et al., 2007; Miyazaki et al., 2014) . b4 subcellular localization is similar to that of the other b subunits, being enriched at the AIS, nodes of Ranvier, and along the length unmyelinated axons (Buffington and Rasband, 2013; Miyazaki et al., 2014) . In the PNS b4 is most highly expressed in medium and large A fibers (Lopez-Santiago et al., 2006; Zhao, O'Leary et al., 2011) .
While not much is known about the trafficking of b subunits down the axon, this process likely involves interactions with VGSC a subunits. Disruption of the disulfide bond between a subunits and b2 or b4 impairs the ability of b subunits to traffic to axons and nodes of Ranvier (Chen et al., 2012; Buffington and Rasband, 2013) .
Similarly, an Scn1b mutation that interferes with a-b1 association results in failure of the mutant b1 to traffic from the soma to the AIS and nodes of Ranvier (Kruger, O'Malley et al., 2016) . This suggests b1 subunit enrichment in axonal domains is dependent on trafficking of aÀb complexes rather than to b subunit independent trafficking. This would imply dynamic association of b1 with a subunits, as b1 in the paranode of nodes of Ranvier is not associated with a subunits (Kazarinova-Noyes et al., 2001; . b subunits are also expressed in various glia where they may function as cell adhesion guides and cues for neurodevelopment, including coordinating neurite outgrowth, axonal fasciculation, and neuronal migration .
Section 2: b subunits in physiology and development
The cell type specificity of b subunit expression, b subunit specific interactions with other proteins, and unique b subunit structural features outlined in section 1 are important for cell type and brain region specific control of excitability and development. In the following section we will examine the physiological functions of the b subunits at the level of control of VGSC and voltage gated potassium (VGKC) channel currents, structural development in the nervous system, and impacts on excitability.
Section 2 part 1: b subunits alter VGSC properties
VGSCs undergo a series of conformational changes resulting in several channel states necessary for neuronal AP firing. The b subunits have specific effects on these states and contribute unique gating mechanisms. The "closed" (deactivated) state dominates at negative membrane potentials. In this state, channels do not pass ions. Upon membrane depolarization, the channels undergo conformational shifts to the "open" state, allowing passage of ions. Channels may then revert back to the closed state or undergo the process of "inactivation," whereby the intracellular face of the channel is blocked by an inactivating "particle" and ion passage is blocked. Relief from inactivation occurs upon hyperpolarization for extended periods of time and is much slower than deactivation, leading to the refractory period between APs (Hille, 2001) . Early work expressing a subunits in heterologous systems showed that a subunits alone contain all the machinery necessary for these processes (Noda et al., 1986; Tomiko et al., 1986; Recio-Pinto et al., 1987) . However, the activation and inactivation kinetics of TTXsensitive a subunits expressed in Xenopus oocytes without b subunits are slower than properties observed for native VGSC expression. The voltage dependence of I Na is also altered (Goldin et al., 1986; Auld et al., 1988; Trimmer et al., 1989; Joho et al., 1990 ). The first indication that b subunits were necessary to reconstitute native channel properties was found by coinjection of low molecular weight brain mRNA (containing b subunit transcripts) with high molecular weight mRNA (containing a subunit transcripts). The low molecular weight mRNA fraction conferred native kinetics and voltage dependence on I Na expressed by the high molecular weight mRNA fraction . Cloning of Scn1b and Scn2b cDNAs and their coexpression with a subunits in Xenopus oocytes revealed that b subunits are indeed responsible for these differences as well as promotion of the surface expression of a subunits (Isom and De Jongh, 1992; Isom et al., 1995) .
The effects of b subunits on channel cell surface expression, activation, and inactivation are dependent on the particular b subunit expressed, the chosen experimental expression system, and which a subunit is coexpressed. An overview of the effects of b subunits on channel gating and trafficking in heterologous cells is provided in (Calhoun and Isom, 2014) . Some possible reasons for these differences include background expression of other b subunits in some heterologous cell lines and cell line dependent differential posttranscriptional processing of b subunits. Sialic acid terminated glycosylation in particular seems to be important for modulation of a subunit gating by b1. Sialic acid terminated glycosylation on residues within the b1 Ig loop may confer electrostatic interactions with residues in a subunit voltage sensing domains. In addition, the presence of a high degree of sialic acid terminated glycosylation in Na v 1.4 is thought to confer resistance to modulation by or association with b1. This is restored by mutating Scn4a cDNA to contain non-glycosylatable residues. This modification is also necessary for the effects of b subunits in promoting Na v 1.4 cell surface expression, and thus may facilitate intersubunit association rather than mediate gating differences in skeletal muscle (Johnson et al., 2004) . Differential sialic acid modification was also found to affect b2 modulation of Nav1.5 while, in the same study, Nav1.2 was modulated regardless of a subunit sialylation status (Johnson and Bennett, 2006) . The epilepsy-linked b1-C121W mutation in Scn1b results in decreased b1 subunit glycosylation and loss of its capacity to modulate VGSC properties and to traffic out of the soma to the axon in mouse neurons (Meadows et al., 2002; Tammaro et al., 2002; Kruger, O'Malley et al., 2016) . This raises the possibility that control of glycosylation of b subunits, especially sialyation, may be important in subcellular targeting and a-b subunit association. Interestingly b1 and b3 oppositely affect glycosylation of Nav1.7 in heterologous systems, showing b subunits can also control gating of a subunits via regulation of their posttranscriptional processing (Laedermann et al., 2013) . Modulation of I Na by b subunits is also dependent on phosphorylation status. Phosphorylation of S161 in the C-terminal tail of b3 is necessary for modulation of Nav1.2 I Na in heterologous cells (Merrick et al., 2010) . Phosphomimetic mutation of residue Y181, located in the b1 C-terminal tail, results in the loss of b1's capacity to modulate Nav1.2 mediated I Na and surface expression, without interfering with a-b subunit association . Tyrosine phosphorylation of b1 is likely functionally relevant in neurons, as the b1 intracellular domain is known to interact with receptor protein tyrosine phosphatase b (RPTP-b) and likely Fyn kinase in mouse brain, as Fyn null neurons lack b1-mediated neurite outgrowth (Ratcliffe et al., 2000; Brackenbury et al., 2008) . In contrast to b1, b2 does not interact with RPTP-b, suggesting b subunit specificity of association with certain phosphorylation enzymes (Ratcliffe et al., 2000) . Thus, differential posttranscriptional modifications to b subunits, including glycosylation and phosphorylation, may lend modularity to channel activity in a cell type and subcellular region specific manner.
Section 2 part 2: in vivo effects of b subunits on VGSC function
Surprisingly, despite high expression throughout the hippocampus and large effects on I Na in heterologous systems, acutely dissociated Scn1b null whole hippocampal pyramidal neurons or CA3 bipolar neurons show no changes in I Na density or voltage dependent properties Patino et al., 2009 ). This may be due to the process of dissociation, compensation by other b subunit gene expression, or only subsets of neurons being affected by Scn1b deletion. The latter is likely, since the mix of several pyramidal neuron populations present in whole hippocampal neuron dissociations could obscure differences in specific hippocampal fields. Notably, in Scn1b null CA3 but not CA1 pyramidal neurons or dentate granule neurons, there is a reduction in the expression of Na v 1.1 and an increase in the expression of Na v 1.3 measured by immunohistochemistry . Fittingly, acutely dissociated dentate granule neurons and CA1 pyramidal neurons show no changes in I Na density, kinetics, or voltage dependent properties (Uebachs et al., 2010; Uebachs et al., 2012) . In contrast, acutely dissociated Scn1b null dorsal root ganglion (DRG) neurons show a depolarizing shift in the voltage dependence of TTX-S I Na inactivation, reduced cell surface expression of Na v 1.9, and a prolonged recovery from inactivation of TTX-R I Na compared to wildtype (WT) . While cultured cerebellar granule neurons show no change in the amount or voltage dependence of transient I Na , they do have differences in a subunit expression and decreased resurgent I Na , as discussed in more detail in section 2 parts 3 and 4 (Brackenbury et al., 2010) .
Scn2b deletion also shows cell type dependent effects in native neurons. Cultured hippocampal neurons from Scn2b null mice have reduced surface expression of TTX-S VGSCs. Acutely dissociated Scn2b null hippocampal pyramidal neurons, but not dentate granule neurons, have reduced I Na density (Chen et al., 2002; Uebachs et al., 2010) . Scn2b deletion also affects the gating properties of VGSCs, slowing the kinetics of activation and inactivation in dissociated hippocampal neurons. Scn2b null small fast DRG neurons show a 50% reduction in transient I Na , reduced Na v 1.7 expression, and slowed kinetics of activation and inactivation. These effects of Scn2b appear to be specific to TTX-S channels, as TTX-R I Na in the PNS are unchanged, perhaps due to the lack of b2-binding cysteine residues in the TTX-R PNS channels Nav1.8 and Nav1.9, as discussed in section 1 (Lopez-Santiago et al., 2006) .
Differential effects of Scn2b deletion on VGSC a subunit subtypes within the same neuron demonstrate that b subunits modulate channels in precise ways in vivo.
The effects of b3 in the nervous system in vivo are not well studied, however Scn3b deletion results in reduced transient I Na and hyperpolarized voltage dependence of inactivation in cardiomyocytes, suggesting the effects of b3 observed in heterologous system may hold in vivo (Hakim et al., 2008) .
Scn4b knockdown in cultured cerebellar granule neurons results in reduced transient I Na and hyperpolarization of the voltage dependence of transient I Na availability (Bant and Raman, 2010) . Scn4b null mice show no changes in transient I Na in striatum, but see below for effects on special gating schemes (Miyazaki et al., 2014) . Overexpression of Scn4b cDNA in cultured hippocampal CA3 neurons, which do not natively express b4, hyperpolarizes and decreases the slope factor of the voltage dependence of availability, suggesting effects of b4 in heterologous systems may translate to neurons (Aman et al., 2009 ).
3.3. Section 2 part 3: role of b subunits in resurgent and persistent sodium current b subunits play roles in special gating schemes that differ from the traditional transient I Na described by Hodgkin and Huxley (Hille, 2001) . Resurgent I Na is a specialized current in which traditional inactivation is impaired by blockade of the intracellular face of the pore, which is relieved more quickly by hyperpolarization than traditional inactivation. Upon membrane potential repolarization, the channel is able to quickly convert to the open state without the prolonged recovery interval imparted by traditional inactivation. This current activates quickly upon repolarization during an AP and promotes cell type dependent spontaneous, repetitive, or burst firing of APs (Lewis and Raman, 2014) . The Cterminal tail of b4 is the only known endogenous molecule to generate resurgent I Na (Grieco et al., 2005; Lewis and Raman, 2014) . The residues KKLITFILKKTREK in the C-terminal tail of the mouse b4 subunit are required for resurgent I Na in cerebellar purkinje and granule neurons (Grieco et al., 2005) . Consistent with this result, Scn4b null mice lose resurgent I Na in striatal projection neurons (Miyazaki et al., 2014) . While b4 is the only identified mediator of resurgent I Na to date, there are neuronal populations that express this current but do not express b4, suggesting the involvement of other proteins (Lewis and Raman, 2014) . The ability of b4 to generate resurgent I Na is a subunit dependent, with Na v 1.6 carrying proportionally more than the other a subunits (Lewis and Raman, 2014) . Scn1b null cultured granule neurons have reduced resurgent I Na , likely due to decreased expression of this a subunit (Brackenbury et al., 2010) .
In addition to reduced resurgent I Na , Scn4b null striatal projection neurons also have reduced persistent I Na , defined as the fraction of transient I Na that does not inactivate (Miyazaki et al., 2014) . Persistent I Na promotes repetitive firing, facilitates the summation of excitatory postsynaptic currents, and contributes to determination of firing threshold (Crill, 1996) . Knockdown of b4 in cultured cerebellar granule neurons reduced both resurgent and persistent I Na (Aman et al., 2009) . Inclusion of the C-terminal b4 peptide restored resurgent I Na in these neurons and induced it in neurons that do not typically have resurgent I Na (Grieco et al., 2005) .
Interestingly, in contrast to the b4 C-terminal peptide, expressing the full-length b4 protein does not generate resurgent I Na in heterologous systems. It does, however, destabilize inactivation; tripling persistent I Na amplitude (Aman et al., 2009 ). b4 is not unique in its ability to impact persistent I Na . b3, but not b1 or b2, when coexpressed in heterologous systems with Na v 1.2, increases persistent I Na (Qu et al., 2001 ). Scn1b has effects on both persistent and resurgent I Na in vitro and in vivo. Scn1b null CGNs have reduced resurgent I Na and Scn1b null DRGs have reduced persistent TTX-R I Na (Brackenbury et al., 2010; Lopez-Santiago et al., 2011) . This effect in CGNs may be due more to the loss of effects of Scn1b on Nav1.6 subunit expression, which is known to disproportionality carry resurgent and persistent I Na relative to other a subunits (Lewis and Raman, 2014) .
In summary, many neurons undergo dynamic changes in their firing profile, which may be controlled by the levels of persistent and resurgent I Na expressed (Krahe and Gabbiani, 2004; Paul et al., 2016) . b subunits may play critical roles in neuronal firing based on their impacts to these currents, and thus impart dynamic control over neuronal firing properties.
3.4. Section 2 part 4. b subunits affect trafficking and expression of VGSC a subunits in vivo
The early heterologous expression studies of b1 and b2 revealed that, in addition to modulation of gating, these subunits also impact channel surface expression, largely through effects on trafficking and cell surface half-life of channels rather than through their transcriptional control (but see below) (Schmidt et al., 1985; Schmidt and Catterall, 1986; Isom and De Jongh, 1992; Isom et al., 1995) . Association with b2 is the final step in VGSC biosynthesis, promoting a subunit insertion into the plasma membrane (Schmidt et al., 1985; Schmidt and Catterall, 1986) . In contrast, "free" a subunits not associated with a disulfide-linked b subunit are located inside the cell and are inactive (Schmidt et al., 1985) . In addition, a subunits covalently associated with b subunits are removed from the cell surface more slowly than free a subunits (Schmidt and Catterall, 1986) . Consistent with these data, hippocampal neuron cultures from Scn2b null mice show a reduction in a subunits expressed at the cell surface (Chen et al., 2002) . Interestingly, the function of b2 on VGSC surface expression in mammalian cells appears to be dependent on b1, and this point is discussed in more detail in the next section. In contrast to b2, b4 does not appear to contribute to surface expression of a subunits; Scn4b null neurons show no apparent reductions in transient sodium current (Miyazaki et al., 2014 ).
Scn1b impacts a subunit expression and trafficking in an isoform specific manner in vivo. In CGNs, Scn1b deletion in mice causes a reduction in Nav1.6 and an increase in Nav1.1 expression at the CGN AIS, leaving total current density unchanged (Brackenbury et al., 2010) . In rat brain, while "free" a subunits not disulfide linked to b subunits account for 21% of VGSCs in the soma, they are wholly undetectable in synaptosomes. This suggests that b2 or b4 subunits may play roles in directing a subunits to the synapse (Schmidt et al., 1985; Schmidt and Catterall, 1986 ). More recent work shows that b3 mediates clustering of Na v 1.5 channels in heterologous systems, possibly through cis homophilic interactions resulting in b3 trimer formation (Namadurai et al., 2014) . VGSC a subunit single molecule tracking microscopy in fetal rat hippocampal neuron cultures showed that VGSCs exist in clustered microdomains (Akin et al., 2016) . While the role of b subunits in this clustering is unknown, data showing the effects of b3 on VGSC clustering in culture may lend important insights into this process, since b3 is highly expressed in fetal and postnatal rodent brain. b3 also may affect a subunit expression through masking of an endoplasmic reticulum retention/retrieval motif, although this effect may be limited to Nav1.8 (Zhang et al., 2008) . Scn4b deletion does not affect axonal expression of Nav1.2 in striatal projection neurons, suggesting that it may not play roles in channel trafficking but instead its function may be limited to specialized impacts on persistent and resurgent sodium currents (Miyazaki et al., 2014) .
b subunits can affect VGSC a subunit transcription or translation.
In Scn1b null hippocampus, CA3, but not CA1 or dentate gyrus, pyramidal neurons have reduced Nav1.1 and increased Nav1.3 expression . In addition, Nav1.9 protein is reduced in Scn1b null DRGs . b2 is also able to affect expression of specific a subunits. In DRGS, mRNA for Nav1.7, Nav1.6 and Nav1.3 is reduced, while Nav1.1 and Nav1.7 protein are reduced, with no change in Nav1.6 (Lopez-Santiago et al., 2006) . Many of these effects on specific VGSC a subunit expression may be due to transcriptional regulatory effects of b subunits, as discussed in the next section.
3.5. Section 2 part 5. proteolytic processing of b subunits VGSC b subunits are targets for proteolytic cleavage, with the resulting products demonstrating specific autonomous functions.
The b subunits contain cleavage sties for sequential cleavage by BACE1 and g-secretase (Wong et al., 2005; Gersbacher et al., 2010) . b2, and likely the other b subunits, contains an additional cleavage site for a-secretase enzyme ADAM10 in the extracellular portion (Kim et al., 2005) . BACE1 cleavage results in shedding of the extracellular b subunit domain. For b1, this cleaved polypeptide fragment is thought to be capable of functioning as a ligand for cell adhesion, similar to b1b (Kim et al., 2005; Wong et al., 2005) . Interestingly, while expression of full-length b4 subunits with a subunits in heterologous systems does not recapitulate resurgent I Na , cleavage of b4 by BACE1 slows the decay of resurgent I Na , suggesting that proteolytic processing of b4 may be involved in generation of resurgent I Na (Huth et al., 2011) . Because the b4 residues responsible for generating resurgent I Na are located within the C-terminal tail, sequential cleavage by g-secretase, following the action of BACE1, may also be important in this mechanism.
Formation and nuclear translocation of the g-secretase cleaved b2 C-terminal fragment has been shown to lead to increased Nav1.1 subunit mRNA and protein expression in neurons, suggesting a role for b subunits in the regulation of a subunit transcription (Kim et al., 2007) . While similar roles for the other b subunits have not been investigated, their processing by this cleavage pathway and effects on specific a subunit expression may suggest similar mechanisms. Thus, b subunits may also affect neuronal firing through the modulation of channel transcription.
3.6. Section 2 part 6. b subunit crosstalk VGSC b subunits can also impact the actions of each other. Coexpression of b1 and b2 in oocytes with Nav1.2 increases I Na density greater than either b subunit alone, suggesting synergistic action (Isom et al., 1995) . In Chinese hamster lung fibroblasts, b2 expression does not increase the surface expression of Nav1.2 unless b1 is also expressed (Kazarinova-Noyes et al., 2001; . This seem to be the case for endogenous expression as well; mice that are homozygous for both the Scn1b and Scn2b null alleles have reduced I Na density in cerebellar purkinje neurons but I Na density is not different in mice null for Scn1b or Scn2b alone (Grieco et al., 2005) . This result suggests there is a capacity for b1 and b2 to compensate for each other in vivo, in spite of evidence that these subunits bind to different locations on a subunits. This may be the case for other subunits as well. Scn3b null mice have apparently normal nervous system development, suggesting compensatory Scn1b expression (Hakim et al., 2008; Hakim et al., 2010) . Coexpression of b1 with b4 overcomes b4 induced persistent I Na in heterologous cells and neurons. Additionally, the b4 mediated hyperpolarized activation and inactivation of Nav1.1 I Na are antagonized by b1. In contrast, b1 functions appear to be relatively unaffected by b4 co-expression, as cells expressing both subunits match the electrophysiological profile of b1 expression alone. These data suggest opposing roles of b1 and b4 in the same trimeric channel complex, with b4 acting as an excitation accelerator and b1 acting as an overriding brake (Aman et al., 2009) . While the binding sites on a subunits for b1 and b3 are predicted to be competitive, there is evidence that b1 and b3 coexpression can generate properties not present with either alone when coexpressed with Nav1.5 (Ko et al., 2005) . This may be specific to the a subunit, as similar experiments with Nav1.8 show the opposing shifts in channel availability with b1 and b3 seem to cancel when coexpressed in the same oocyte. In the same study, b1 and b2 coexpression revealed a depolarizing voltage shift in availability, contrary to the hyperpolarizing shift of b1 alone or the absence of effect of b2 alone (Vijayaragavan et al., 2004) . b subunits can also affect expression of other b subunits in vivo. Quantification of b subunit proteins in Scn4b null mice showed increased expression of b1 and reduced b2 in spinal cord and cerebellum, with no effect on their expression levels in striatum or cortex (Miyazaki et al., 2014) . In DRG neurons, Scn2b null mice have decreased expression of Scn3b and Scn4b but not Scn1b mRNA (Lopez-Santiago et al., 2006) . This cell type specific regulation of b subunit mRNA expression by other b subunits further highlights the precise control of b subunit function in vivo.
3.7. Section 2 part 7: b subunits modulate potassium channels b subunits also affect some potassium currents (I K ), creating the potential for cross-talk between VGKCs and VGSCs. b1 subunits interact with K v 4.2 and Kv4.3, major contributors to A-type I K in brain. This interaction was first uncovered in heterologous expression studies (Deschênes and Tomaselli, 2002) . Later, an unbiased proteomic approach designed to discover novel K v 4.2 interacting partners in rodent brain identified VGSC b1. In the same study, investigators found that heterologous co-expression of b1 with K v 4.2 increases I K density. In addition, shRNA knockdown of b1 in cultured cortical neurons decreased A-type I K (Marionneau et al., 2012) . b1 also modulates several other VGKCs when coexpressed in Xenopus oocytes, including K v 4.3, K v 1.1, K v 1.3, K v 1.6, and K v 7.2. b1 did not, however, modulate Kv3.1 in this study, suggesting that interactions are moderately specific to channel type (Nguyen et al., 2012) . It will be important to test these interactions in native neurons and cardiomyocytes because b1 interactions are known to be dependent on cell type and these interactions may be limited to heterologous overexpression systems. VGKC modulation by b1 may be cell type dependent as well. CA1 pyramidal neurons express a high level of K v 4.2 mediated A-type I K but their excitability is largely unaffected in Scn1b null or homozygous mutant neurons Patino et al., 2009; Uebachs et al., 2010; Reid et al., 2014) . Scn1b null mice exhibit reduced transient outward I K in DRG neurons, demonstrating that the effects of b1 on VGKCs is not limited to the brain . Potential effects of other VGSC b subunits on VGKCs in the nervous system have not been investigated, however, large effects on I K in Scn2b null mouse cardiomyocytes suggest that other b subunits may also modulate VGKC function (Bao et al., 2016) .
Section 2 part 8: b subunit function in brain development
VGSC b subunits function in nervous system development on several levels, including neurite outgrowth, axonal pathfinding, dendritic arborization, neuronal patterning, and cell migration.
Neurite extension of WT CGNs plated on b1 expressing fibroblast monolayers is increased compared to control monolayers and requires b1-b1 trans homophilic cell adhesion. In contrast, b2 expressing fibroblast monolayers reduce neurite outgrowth of WT CGNs and b4 has no detectable effects. b1 function in neurite outgrowth requires both cell-cell adhesion and sodium channel activity, particularly current carried by Na v 1.6. Deletion of Cntn1, Fyn, or Scn8a or the addition of TTX abrogated b1-mediated neurite outgrowth in CGNs. Unlike other CAMs, b1 dependent neurite outgrowth is independent of the FGF mediated neurite outgrowth pathway. Scn1b null mice have several nervous system structural defects that may be directly related to altered neurite outgrowth. These include cerebellar parallel fiber defasiculation, CGN axonal mistargeting, dentate granule neuron axonal mistargeting, corticospinal tract defasiculation, and decreased dendritic arborization in pyramidal neurons of the subiculum (Brackenbury et al., 2008; Brackenbury et al., 2010; Brackenbury et al., 2013; Reid et al., 2014) . Structural defects in Scn1b null brain go beyond the regulation of neuronal process extension, also impacting cell migration, proliferation, and neuronal patterning defects. In the cerebellum there is an expansion of the external germinal layer and in the hippocampus there is increased proliferation of dentate granule neurons, ectopic Prox1 positive neurons, and increased thickness of the dentate gyrus granule cell layer with a reduction in dentate granule neuron number (Brackenbury et al., 2008; Brackenbury et al., 2013) .
3.9. Section 2 part 9: differential effects of b subunits on excitability
The wide array of b1-mediated effects on neuronal excitability is consistent with the multi-functionality of b1. Several of these effects can be linked directly to modulation of VGSC a subunit expression and function, while others are attributable to VGKC modulation or altered neuronal morphology. Scn1b deletion in mice results in differential effects on excitability at the single neuron level with some populations showing increased excitability, some decreased, and others unaffected. Cultured Scn1b null CGNs show a decrease in the number of APs fired in response to depolarizing current injections compared to WT (Brackenbury et al., 2010) . There are no measureable changes in the level of transient I Na in these cells, but instead a decrease in the level of resurgent I Na , which is known to be important in repetitive firing of these neurons (Brackenbury et al., 2010; Lewis and Raman, 2014) . Many Scn1b null neuron populations, including dentate granule neurons, CA1 pyramidal neurons, and hippocampal interneurons, have unaffected excitability profiles compared to WT (Patino et al., 2009; Uebachs et al., 2010; Uebachs et al., 2012) . Scn1b null optic nerve has reduced speed of the fastest component of the compound AP, suggesting decreased excitability .
The reported differential effects on excitability appear to be dependent on different functions of Scn1b. Scn1b null cortical layer 5 pyramidal neurons fire more APs compared to WT with an increased action potential half width, indicating loss of b1 modulation of K v 4.2 may be a factor (Marionneau et al., 2012) . However, in homozygous knockin mice expressing the epilepsy causing Scn1b-C121W mutation, this population is unaffected (Reid et al., 2014) . While these results are seemingly at odds, they may provide clues to even more nuanced differences in the effects of Scn1b on neuronal excitability. The b1-C121W mutation interferes with both a subunit interaction and cell adhesion but with unknown impact on modulation of VGKCs (Meadows et al., 2002; Kruger, O'Malley et al., 2016) . This may indicate subpopulations of the same neuron type in different regions of cortex may be affected in different ways or that C121W mutants may modulate excitability differently than total loss of Scn1b. The latter may be the case because C121W heterozygous mice have increased seizure susceptibility relative to Scn1b þ/-mice (Kruger, O'Malley et al., 2016) .
Hyperexcitability has been found in layer 2/3 pyramidal neurons and pyramidal neurons of the subiculum in mice homozygous for the b1-C121W mutation. These increases in excitability can be attributed to differences in structural development of these neurons, as they have increased input resistance and reduced cell surface area, measured by whole cell capacitance and immunohistochemistry, respectively (Reid et al., 2014) . Interestingly, this may be a way that reductions in VGSC function can drive hyperexcitability via cross-talk between I Na and neuronal development. The effects of Scn2b on excitability are not as well studied as those of Scn1b. We do know, however, that Scn2b null mice have increased threshold and reduction in amplitude of extracellularly recorded compound APs in the optic nerve, suggesting that reduced levels of VGSCs at the cell surface result in reduced excitability. Scn2b deletion also increases susceptibility to pilocarpine-induced seizures, suggesting aberrant neuronal excitability elsewhere in the CNS (Chen et al., 2002) . While the effects of Scn2b deletion on DRG AP firing have not been measured, altered VGSC function and reduced pain sensitivity in Scn2b null mice suggest reduced DRG neuron excitability (Lopez-Santiago et al., 2006) .
The effects of Scn3b on nervous system excitability have not been reported, but there is extensive work showing impacts on cardiomyocyte excitability (Hakim et al., 2008; Hakim et al., 2010 ).
Scn4b's effects on neuronal excitability appear to be largely related to its role in regulating persistent and resurgent I Na . Scn4b null mice have reduced repetitive firing of APs in striatal projection neurons and Scn4b knockdown in cultured CGNs causes reduced excitability, suggesting that reductions in resurgent I Na impact excitability (Bant and Raman, 2010; Miyazaki et al., 2014) . In a similar manner, reduced persistent and resurgent current in Scn1b null CGNs decrease excitability (Brackenbury et al., 2010) .
Section 3: b subunits in diseases of the nervous system
b subunits play important roles in both the mechanism and treatment of several disorders of the nervous system. The underlying links between b subunit gene mutations and these disparate diseases result from the numerous biochemical and physiological functions outlined in sections 1 and 2. Some can be linked to effects on neuronal and network excitability, while others may be associated with the effects of b subunits in brain development. The most direct link to disease is between mutations in SCN1B and epilepsy. SCN1B mutations in human patients are linked to three pediatric epilepsies: generalized epilepsy with febrile seizures plus (GEFSþ), benign familial infantile epilepsy, and the pediatric epileptic encephalopathy Dravet syndrome (DS). Links also exist between the b subunits and several other disorders including neuropathic pain, neurodegenerative diseases, neurodevelopmental disorders, and sudden infant death syndrome (SIDS). Thus, b subunits are important and novel therapeutic targets due to their unique expression profiles, functions, and pharmacology.
Section 3 part 1: b subunits and epilepsy
Epilepsy is a condition characterized by unprovoked recurrent seizures (Fisher et al., 2014) . Up to 40% of epilepsy cases have unknown origin (Beck papers for citation). Exceptions to this are the genetic epilepsies, which can often be linked directly to specific ion channel gene mutations. Mutations in several VGSC genes, including SCN1B, are known to cause epilepsy (Meisler, O'brien et al., 2010) . One of the first identified mutations linked to human epilepsy was SCN1B-C121W that results in GEFSþ (Wallace et al., 1998) . GEFSþ is characterized by early pediatric seizures associated with fever followed by febrile and afebrile seizures. GEFSþ is one of a multitude of genetic pediatric epilepsies associated with VGSC mutations. The most extreme of these VGSC related epilepsies is Dravet syndrome, a debilitating epileptic encephalopathy resulting in severe epilepsy, ataxia, cognitive impairment, autism, sleep abnormalities, and a high risk of sudden unexpected death in epilepsy (SUDEP) (Scheffer et al., 2010; Skluzacek et al., 2011) . More than 70% of DS cases are caused by de novo loss-of-function mutations in SCN1A, however a small subset has been identified to have inherited homozygous mutations in SCN1B (Patino et al. 2009 , Scheffer et al. 2010 , Ogiwara et al. 2012 , Ramadan et al. 2017 . The first of the SCN1B associated DS cases identified was a loss of function mutation, SCN1B-R125C that results in failure of b1 subunits to traffic to the cell surface (Patino et al., 2009) . Simple lossof-function is a viable explanation for the mechanism of SCN1B-linked DS, as Scn1b null mice recapitulate the full DS phenotype, including frequent spontaneous seizures, ataxia, developmental delay, and early lethality . This phenotype is more severe than is found in Scn1a DS mice. 100% of Scn1b null mice die by postnatal day (P)21, which may explain the limited detection of patients with homozygous SCN1B mutations in the human population . Even though b1-C121W polypeptides are expressed at the neuronal cell surface, mice homozygous for the GEFS þ mutation, Scn1b-C121W, recapitulate the phenotype of Scn1b null mice, suggesting loss-of-function of a cell surface expressed subunit (Reid et al., 2014; Kruger, O'Malley et al., 2016) . Interestingly, mice heterozygous for the Scn1b-C121W allele have increased susceptibility to febrile seizures compared to mice heterozygous for the Scn1b null allele (Kruger, O'Malley et al., 2016) . Differences in excitability at the single neuron level are not always consistent between the Scn1b null and Scn1b-C121W homozygous mouse models (Marionneau et al., 2012; Reid et al., 2014) . Several defects in AP waveforms in Scn1b-C121W heterozygous mice are absent in Scn1b-C121W homozygous mice (Wimmer et al., 2010; Reid et al., 2014) . Thus, SCN1B associated GEFSþ and DS likely have distinct mechanisms.
A SCN1B mutation specific to b1b, G25R, was identified in multiple pedigrees with idiopathic epilepsy (Patino et al., 2011) . Excluding this mutation, all the SCN1B epilepsy-causing mutations are within or near the Ig domain, which is important in both a subunit modulation and cell adhesion as described in section 1. Importantly, in the Scn1b null mouse, developmental defects appear prior to the onset of seizures or evidence of altered neuronal excitability, suggesting a causative effect of aberrant brain development on altered excitability (Brackenbury et al., 2013) . As described in section two, the hyperexcitability of homozygous Scn1b-C121W subicular pyramidal neurons and cortical layer 2/3 pyramidal neurons appears to be a result of decreased cell size (Reid et al., 2014) . Importantly, specific deletion of Scn1a in forebrain GABAergic interneurons is sufficient to phenocopy DS in mice Ogiwara et al., 2013) . Little is known about altered interneuron function in Scn1b models of DS, but initial experiments in hippocampal interneurons suggest that they are not affected (Patino et al., 2009; Reid et al., 2014) . Given the brain region and cell type specificity of b1 subunit expression discussed in section 2, it is important to expand our understanding of b1 function in the CNS to different neuron types. This may be a useful guide for understanding the exact microcircuit components that are altered in DS and GEFSþ and help us to understand how similar epileptic phenotypes may arise from different mechanisms in specific cell populations.
b subunits are also important in the treatment and pathophysiology of other epilepsies. Approximately 30% of epilepsy patients lack adequate seizure control with existing antiepileptic drugs (AEDs) for unknown reasons (Kwan and Brodie, 2000) . The actions of b subunits affect the efficacy of two known AEDs, carbamazepine and phenytoin (Lucas et al., 2005; Uebachs et al., 2010; Uebachs et al., 2012) . A GEFS þ -linked SCN1B mutation causes a reduction in the efficacy of phenytoin, attenuating the drug's effects on frequency dependent block of sodium current (Lucas et al., 2005) . The effects of carbamazepine are also affected by b subunits. Scn1b null neurons show a paradoxical increase in persistent current when treated with carbamazepine, abolishing the usual spiking attenuation caused by this drug (Uebachs et al., 2010; Uebachs et al., 2012) . Recently, a case study of a family with benign familial infantile epilepsy identified an SCN1B splicing variant as a disease modifier or part of an oligogenic predisposition in this family (Usluer et al., 2017) .
VGSC b subunit expression is differentially impacted in several forms of epilepsy. In pilocarpine induced seizures, there is a downregulation of Scn1b and Scn2b mRNA following status epilepticus with impacts on sodium current consistent with known functions of these two subunits (Gastaldi et al., 1998; Ellerkmann et al., 2003) . This result may be model or species dependent, as there is no evidence for similar increases in temporal lobe epilepsy patients (Gassen et al., 2008) . There is however, a reduction in SCN3B and b3 expression in the hippocampus of temporal lobe epilepsy patients and increased SCN1B and b1 in reactive astrocytes of both epileptic and non-epileptic brain trauma patients. (Gorter et al., 2002; Aronica et al., 2003; Gassen et al., 2008; Das et al., 2012) .
4.2. Section 3 part 2: b subunits in sudden unexpected death in epilepsy and sudden infant death syndrome Sudden Unexpected Death in Epilepsy (SUDEP) is defined as death in patients with epilepsy that is not due to status epilepticus, trauma or drowning (Nashef et al., 2012) . SUDEP occurs at a high rate among DS patients, with a 6-fold increase in risk above other epilepsies and 24-fold higher risk of sudden death than in the general population (Skluzacek et al., 2011) . As mentioned above, 100% of Scn1b-DS mice die by P21. This phenotype is more severe than for Scn1a DS mouse models and other models of SUDEP, such as the Kcna1 null mouse, which exhibit death rates of~50% and 25%, respectively Frank et al., 2006; Glasscock et al., 2010) . This positions the Scn1b null mouse as a reliable model in the study of SUDEP mechanisms. While the mechanism of SUDEP is not understood, it likely involves a "perfect storm" of catastrophic events. Proposed mechanisms of SUDEP include the effects of seizures on the brain and other organ systems resulting in spreading depression to the brain stem, autonomic dysfunction, cardiac arrhythmias, apnea, or pulmonary edema. SUDEP in DS patients typically occurs in the night and thus may involve defects in the autonomic nervous system, resulting in shutdown of breathing or arousal centers, as well as cardiac arrhythmias (Goldman et al., 2009 ). In addition to severe seizures, Scn1b null mice have cardiac arrhythmias, the combination of which may result in sudden death (Lin, O'malley et al., 2015) . SIDS may also be related to b subunit dysfunction. The cause of SIDS remains unclear and likely varies. Sleep position is a known SIDS risk factor but genetic factors including b subunit gene mutations are now known to contribute (Krous et al., 2004; Tan et al., 2010) . Several instances of SIDS have been linked to SCN3B and SCN4B mutations (Tan et al., 2010) . Scn4b null mice have spontaneous unexplained death without an apparent seizure phenotype, but this occurs post development and may be unrelated to SIDS (Miyazaki et al., 2014) .
Mutations in b subunits may be related to SIDS through malfunctions of their roles in the heart, but there are also several overlaps between CNS developmental malformations and reactive astrogliosis in SIDS and the deficits seen in b subunit null models (Kinney et al., 1991; Cruz-S anchez et al., 1997; Gorter et al., 2002; Aronica et al., 2003; Paine et al., 2014) .
4.3. Section 3 part 3: b subunits and pain b subunits are involved in both nociceptive and neuropathic pain, and are expressed in fiber types responsible for pain sensation, as outlined in section 2. Thus, the normal pain sensing pathways that encode information through firing rates may be dependent on the differential expression of b subunits. Deletion of Scn1b results in DRG neuron hyperexcitability, predicting that these mice have allodynia . In contrast, Scn2b deletion results in insensitivity to inflammatory and neuropathic pain paradigms (Lopez-Santiago et al., 2006) . Several pain models show perturbations of b subunit protein or mRNA expression. Scn1b mRNA is increased in dorsal horn neurons in a constrictive nerve injury model (Blackburn-Munro and Fleetwood-Walker, 1999) . In several injury models the expression levels of b2 mRNA and protein are perturbed in a cell type and injury specific manner, suggesting unique pathways for b2 regulation in different cell types and injury paradigms (Coward et al., 2001; Pertin et al., 2005; Lopez-Santiago et al., 2006) . Scn3b is upregulated in a fiber type dependent manner in several different nerve injury models, further suggesting that the cell type specificity of b subunit expression is important in the generation of acute and chronic pain Takahashi et al., 2003) . Scn4b siRNA delivered to the DRG interferes with mechanical hypersensitivity in a radicular pain model. In this model, Scn4b siRNA interferes with increases in transient and resurgent current present in cultured DRG neurons following inflammation induction (Xie et al., 2016) . b4 may be Fig. 2 . A multitude of functions of voltage gated Na þ channel b subunits in the nervous system. A. b subunits modulate VGSC trafficking to the cell surface . Sequential cleavage by BACE 1 and g secretase alters transcription, including VGSC a subunits, and releases the Ig loop (similar to b1B) as an extracellular signaling molecule (Wong et al., 2005; Gersbacher et al., 2010; Patino et al., 2011) . B. Each b subunit has been shown to modulate VGSC gating. b subunits alter the AIS localization of specific a subunits and can mediate clustering of a subunits (Brackenbury et al., 2010; Namadurai et al., 2014) . Loss of b1 expression alters axonal fasiculation and targeting . b1 in nodes of ranvier associate with a subunits, likely modifying their function. b1 in paranodes is engaged in heterophilic cell adhesion complexes independently of a subunits (Kazarinova-Noyes et al., 2001; . Loss of b2 ameliorates symptoms of multiple sclerosis, likely through axonal-oligodendrocyte interaction . a subunits in the absence of b2 or b4 fail to enrich in synaptosomes, suggesting roles in VGSC expression at the synapse (Schmidt et al., 1985; Schmidt and Catterall, 1986) . b1 facilitates neurite outgrowth at growth cones, requiring I Na (Brackenbury et al., 2010) Mutation of b1 decreases dendritic arborization, influencing input resistance and excitability (Reid et al., 2014) . b1 is upregulated in reactive astrocytes (Aronica et al., 2003) . mechanistically important in SCN9A-linked paroxysmal extreme pain disorder. In this model, there is an increase in DRG excitability and resurgent current sodium current carried by Na v 1.7, which may be regulated in vivo by b4 (Theile et al., 2011) . The unique expression profile of each b subunit may make them valuable targets for pain therapeutics. For example, because b1 subunits are already known to impact the pharmacology of pain related drugs such as lidocaine and several neurotoxins, they may be readily targetable.
4.4. Section 3 part 4: b subunits in demyelinating and neurodegenerative disorders
There are several lines of evidence to show that b subunits are important in demyelinating and neurodegenerative disorders. Scn1b null mice have defects in myelination in the CNS and PNS, including a reduction in the number of nodes of Ranvier in the optic nerve, improper paranodal development in CNS and PNS, brain and spinal cord dysmyelination, and increased axonal degeneration . While the axo-glial cell adhesive complexes at paranodes involving b1, contactin-1, Caspr, and NF-155 are obvious candidates for this defect, the impact of sodium current defects may also be important, as channel activity is involved in the establishment of myelination (Gibson et al., 2014) . While Scn2b null mice have normal myelination, Scn2b deletion ameliorates disease severity in a mouse model of experimental allergic encephalomyelitis (EAE), showing decreased axonal degeneration, fewer demyelinated and dysmyelinated fibers, reduced death, and reduced symptom severity compared to WT mice (Chen et al., 2002; O'Malley et al., 2009) . Interestingly, MS patient cerebrospinal fluid has decreased BACE1 activity, suggesting that cleavage of the b subunits may be impacted and thus clinically relevant, as disease severity is correlated with the degree of BACE1 reduction (Mattsson et al., 2009 ).
Sequential BACE1 and g-secretase cleavage of b subunits may also be important in Alzheimer's disease. In Alzheimer's disease, cleavage of amyloid precursor protein releases Amyloid b peptide, which accumulates in the brain and forms aggregates (Evin et al., 2010) . Cleavage of the VGSC b subunits involves this same pathway and may underlie the hyperexcitability and increased seizure risk observed in Alzheimer's (Amatniek et al., 2006) . b subunits are also indicated in the pathophysiology of several other neurodegenerative diseases. In an amyotrophic lateral sclerosis model, there is downregulation of Scn1b and upregulation of Scn3b in the ventral dorsal horn, potentially accounting for observed neuronal hyperexcitability there (Nutini et al., 2011) . Scn4b may be important in Parkinson's disease and Huntington's disease, potentially related to its high expression in neurons in the substantia nigra and striatum (Lein et al., 2007; Miyazaki et al., 2014) . In a model of Parkinson' disease, Scn4b mRNA expression, b4 protein expression, and the extent of b4 glycosylation are increased (Zhou, Zhang, Liu, Zhang and Jiao, 2012) . In a model of Huntington's disease, b4 expression is reduced in neurons expressing mutant huntingtin (Oyama et al., 2006) . Scn4b null mice have decreased resurgent sodium current and hypoexcitability in the striatal projection neurons, representing a possible role of altered excitability in striatal neurodegeneration in Huntington's disease (Miyazaki et al., 2014) .
4.5. Section 3 part 5: b subunits in neurodevelopmental and neuropsychiatric disorders Many epilepsy patients have comorbidities including autism, intellectual disability, impaired sleep, and mood disorders (Steffenburg et al., 1996; Levisohn, 2007; Louis, 2011; Lau et al., 2012) . DS in particular is characterized as having high incidences of autism and intellectual disability and Scn1a þ/-mice model autism spectrum disease (Han et al., 2012; Villeneuve et al., 2014) . It is unclear if intellectual disability in DS is the result of epilepsy, single neuron excitability, or altered neuronal development. Altered CNS development in Scn1b null mice may predict intellectual disability and precede the onset of epilepsy and neuronal hyperexcitability (Brackenbury et al., 2013) . Mood disorders are a common comorbidity in epilepsy patients. Mutations in Ank3, encoding ankyrin G, have been found in bipolar disorder (Ferreira, O'Donovan et al., 2008) . Recent work has shown hypoexcitability of parvalbumin positive interneurons in an Ank3 mutant mouse model of bipolar disorder that may link epilepsy and mood disorders (Lopez et al., 2017) . Because ankyrin G is a VGSC b1 interacting protein and reductions in VGSC function in axons are proposed to underlie hypoexcitability of parvalbumin positive interneurons in this model, it is feasible that b subunits play a role in this connection.
Conclusion
The VGSC b subunits are key players in the development of excitability in the nervous system (Fig. 2) . b subunits are more than simple accessories of the pore-forming a subunits and instead confer several unique properties to VGSCs that allow precise control of excitability in a cell type specific manner. b subunit multifunctionality allows for crosstalk between VGSC and VGKC function in the CNS and PNS. The cell adhesive properties of b subunits link neuronal development to excitability. Sodium current impacts brain structural development through b subunit dependent pathways and defects in structure resulting from b subunit gene deletion can drive hyperexcitability. These important properties implicate the VGSC b subunits in the mechanisms and potential treatments of several diseases of the nervous system. The cell type dependent properties and unique pharmacology of b subunits are also emerging as informative research tools to study disease mechanisms and to develop novel therapeutics. While the term channelopathy implies defects in the pore-forming subunit of the VGSC signaling complex, the non-pore-forming components are also critical in physiology and disease.
